Invention Grant
US07641901B2 Immunotherapy of autoimmune disorders using antibodies which target B-cells
有权
使用靶向B细胞的抗体免疫治疗自身免疫性疾病
- Patent Title: Immunotherapy of autoimmune disorders using antibodies which target B-cells
- Patent Title (中): 使用靶向B细胞的抗体免疫治疗自身免疫性疾病
-
Application No.: US11222838Application Date: 2005-09-12
-
Publication No.: US07641901B2Publication Date: 2010-01-05
- Inventor: David M. Goldenberg , Hans J. Hansen
- Applicant: David M. Goldenberg , Hans J. Hansen
- Applicant Address: US NJ Morris Plains
- Assignee: Immunomedics, Inc.
- Current Assignee: Immunomedics, Inc.
- Current Assignee Address: US NJ Morris Plains
- Agency: Rossi, Kimms & McDowell LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K38/21 ; C12P21/08
Abstract:
Antibodies that bind with a B-cell antigen provide an effective means to treat autoimmune disorders. Antibodies and fragments, which may be conjugated or naked, are used alone or in multimodal therapies. The antibodies may be bispecific antibodies which may be produced recombinantly as fusion proteins, or as hybrid, polyspecific antibodies.
Public/Granted literature
- US20060051349A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells Public/Granted day:2006-03-09
Information query
